40 likes | 59 Views
The global atopic dermatitis treatment market is anticipated to showcase considerable growth during the forecast period (2020-2026). The new product launches with rising FDA approvals are a factor contributing to the growth of the market. Atopic dermatitis (a most common and severe form of eczema) is an inflammatory skin condition that affects nearly 30% of the US population, mostly children and adolescents.
E N D
Orion Market Research Atopic Dermatitis Treatment Market Size, Share, Trends, Analysis and Forecast 2020-2026 Request https://www.omrglobal.com/request-sample/atopic-dermatitis-treatment-market a free sample of our report on Atopic Dermatitis Treatment Market: ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404
The global atopic dermatitis treatment market is anticipated to showcase considerable growth during the forecast period (2020-2026). The new product launches with rising FDA approvals are a factor contributing to the growth of the market. Atopic dermatitis (a most common and severe form of eczema) is an inflammatory skin condition that affects nearly 30% of the US population, mostly children and adolescents. A https://www.omrglobal.com/industry-reports/atopic-dermatitis-treatment-market full report of Atopic Dermatitis Treatment Market is available at: Pfizer, Inc., Mylan N.V., Bausch Health Companies Inc., Bayer HealthCare AG, Encore Dermatology, Inc., AbbVie Inc., Allergan PLC, GlaxoSmithKline PLC, and so on are the key players operating in the global atopic dermatitis treatment market. These players are actively involved in adopting different growth strategies such as mergers and acquisitions, partnerships, collaboration, and strategic agreements among others to remain competitive in the market place. New product launches and investment in the R&D is the key strategy adopted by the players of the global market to sustain their marketplace. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/atopic-dermatitis-treatment-market In June 2020, Eli Lily and Company had received positive top-line results from the North American (breeze-ad5) phase 3 study of oral selective JAK inhibitor baricitinib in patients with moderate to severe atopic dermatitis. In October 2019, Dermira, Inc. (fully owned subsidiary of Eli Lily and Company), a biopharmaceutical company had received US FDA approval for Fast Track designation for lebrikizumab, its novel, investigational treatment being evaluated for patients with moderate-to-severe atopic dermatitis. Lebrikizumab is currently being evaluated in two Phase 3 studies, ADvocate 1 and ADvocate 2, to confirm its safety and efficacy in adolescent and adult patients, ages 12 years and older, with moderate-to-severe atopic dermatitis. In March 2018, Sanofi SA received FDA approval for Dupixent (Dupilumab), the first biologic drug approved for patients with moderate-to-severe atopic dermatitis. Global Atopic Dermatitis Treatment Market Segmentation By Drug Class Corticosteroids PDE-4 Inhibitor Emollients Calcineurin Inhibitors Antibiotics Others
By Route of Administration Oral Topical Injectable For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/atopic-dermatitis-treatment-market Global Atopic Dermatitis Treatment Market – Segment by Region North America United States Canada Europe Germany United Kingdom France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific Rest of the World Middle East & Africa Latin America
Company Profiles AbbVie, Inc. Allergan PLC Bausch Health Companies, Inc. Bayer HealthCare AG Beiersdorf, Inc. Encore Dermatology, Inc. Eli Lily and Co. Galderma laboratories, L.P. GlaxoSmithKline PLC LEO Pharma A/S Mylan N.V. Novartis International AG Pfizer, Inc. Regenron Pharmaceutical, Inc. Sanofi S.A. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803-040-404